HK69883A - Therapeutic compounds containing beta-lactams - Google Patents

Therapeutic compounds containing beta-lactams

Info

Publication number: HK69883A
Authority: HK; Hong Kong
Prior art keywords: lactams; compounds containing; therapeutic compounds; containing beta; beta
Prior art date: 1976-01-31

Application number

HK698/83A

Other languages

English (en)

Inventor

Roger John Ponsford

Original Assignee

Beecham Group Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1976-01-31

Filing date

1983-12-15

Publication date

1983-12-23

1976-01-31 Priority claimed from GB3892/76A external-priority patent/GB1574906A/en

1983-12-15 Application filed by Beecham Group Plc filed Critical Beecham Group Plc

1983-12-23 Publication of HK69883A publication Critical patent/HK69883A/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Oncology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Cephalosporin Compounds (AREA)

HK698/83A 1976-01-31 1983-12-15 Therapeutic compounds containing beta-lactams HK69883A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB3892/76A GB1574906A (en)	1976-01-31	1976-01-31	Therapeutic compounds containing - lactams
GB1900276		1976-05-08

Publications (1)

Publication Number	Publication Date
HK69883A true HK69883A (en)	1983-12-23

Family

ID=26238678

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK698/83A HK69883A (en)	1976-01-31	1983-12-15	Therapeutic compounds containing beta-lactams

Country Status (31)

Country	Link
US (2)	US4428958A (de)
JP (1)	JPS5295689A (de)
AR (3)	AR214306A1 (de)
AT (1)	AT351675B (de)
AU (1)	AU515736B2 (de)
BG (1)	BG27751A3 (de)
CA (1)	CA1089471A (de)
CH (2)	CH637655A5 (de)
CS (1)	CS196341B2 (de)
DD (1)	DD128196A5 (de)
DE (1)	DE2702954A1 (de)
DK (1)	DK146940C (de)
ES (1)	ES455404A1 (de)
FI (1)	FI63581C (de)
FR (1)	FR2339616A1 (de)
GR (1)	GR62544B (de)
HK (1)	HK69883A (de)
IE (1)	IE44759B1 (de)
IL (1)	IL51267A (de)
KE (1)	KE3303A (de)
LU (1)	LU76668A1 (de)
MX (1)	MX4950E (de)
NL (1)	NL7700892A (de)
NO (1)	NO770279L (de)
NZ (1)	NZ183117A (de)
PH (1)	PH13924A (de)
PT (1)	PT66071B (de)
RO (1)	RO69712A (de)
SE (1)	SE441359B (de)
SU (1)	SU645583A3 (de)
YU (1)	YU10777A (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1582884A (en) *	1977-05-19	1981-01-14	Beecham Group Ltd	Clavulanic acid derivatives their preparation and use
GB2004541B (en) *	1977-09-16	1982-05-12	Beecham Group Ltd	Ethers of clavulanic acid a process for their preparation and pharmaceutical compositions containing them
DE2963679D1 (en) *	1978-09-05	1982-11-04	Beecham Group Plc	Clavulanic acid derivatives, their preparation and pharmaceutical compositions containing them
EP0018203B1 (de) *	1979-04-21	1983-03-02	Beecham Group Plc	Clavulansäure-Derivate, ihre Herstellung und Verwendung in Arzneimitteln
NZ193687A (en) *	1979-05-17	1982-12-21	Beecham Group Ltd	Clavulanic acid derivatives and pharmaceutical compositions
ZA804670B (en) *	1979-08-03	1981-07-29	Beecham Group Ltd	Derivatives of clavulanic acid, a process for their preparation and their use
NZ199061A (en) *	1980-12-09	1984-10-19	Beecham Group Ltd	9-(n-tetrazolyl)-deoxyclavulanic acids,salts,esters,and pharmaceutical compositions
NZ199200A (en) *	1980-12-23	1984-07-31	Beecham Group Ltd	Clavulanic acid derivatives and pharmaceutical compositions
GB9518917D0 (en) *	1995-09-15	1995-11-15	Smithkline Beecham Plc	Compounds
US5958462A (en) *	1997-05-23	1999-09-28	Mclean; Linsey	Therapeutic bath salts and method of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4039673A (en)	1973-10-30	1977-08-02	Bayer Aktiengesellschaft	Penicillins and cephalosporins and their production
US3983113A (en)	1975-08-15	1976-09-28	Syntex (U.S.A.) Inc.	Cephalosporin type antibacterials

1977
- 1977-01-14 PT PT66071A patent/PT66071B/pt unknown
- 1977-01-14 IL IL51267A patent/IL51267A/xx unknown
- 1977-01-17 YU YU00107/77A patent/YU10777A/xx unknown
- 1977-01-17 PH PH19356A patent/PH13924A/en unknown
- 1977-01-18 GR GR52592A patent/GR62544B/el unknown
- 1977-01-18 NZ NZ183117A patent/NZ183117A/xx unknown
- 1977-01-20 CS CS77387A patent/CS196341B2/cs unknown
- 1977-01-24 US US05/761,712 patent/US4428958A/en not_active Expired - Lifetime
- 1977-01-25 DE DE19772702954 patent/DE2702954A1/de not_active Withdrawn
- 1977-01-26 CH CH94177A patent/CH637655A5/de not_active IP Right Cessation
- 1977-01-26 BG BG035265A patent/BG27751A3/xx unknown
- 1977-01-26 AR AR266318A patent/AR214306A1/es active
- 1977-01-27 ES ES455404A patent/ES455404A1/es not_active Expired
- 1977-01-27 CA CA270,533A patent/CA1089471A/en not_active Expired
- 1977-01-28 IE IE182/77A patent/IE44759B1/en unknown
- 1977-01-28 SE SE7700946A patent/SE441359B/xx not_active IP Right Cessation
- 1977-01-28 MX MX775395U patent/MX4950E/es unknown
- 1977-01-28 FI FI770295A patent/FI63581C/fi not_active IP Right Cessation
- 1977-01-28 SU SU772447048A patent/SU645583A3/ru active
- 1977-01-28 AT AT53477A patent/AT351675B/de not_active IP Right Cessation
- 1977-01-28 AU AU21770/77A patent/AU515736B2/en not_active Expired
- 1977-01-28 LU LU76668A patent/LU76668A1/xx unknown
- 1977-01-28 DK DK38577A patent/DK146940C/da not_active IP Right Cessation
- 1977-01-28 DD DD7700197138A patent/DD128196A5/de unknown
- 1977-01-28 FR FR7702402A patent/FR2339616A1/fr active Granted
- 1977-01-28 NO NO770279A patent/NO770279L/no unknown
- 1977-01-28 NL NL7700892A patent/NL7700892A/xx not_active Application Discontinuation
- 1977-01-29 JP JP917077A patent/JPS5295689A/ja active Granted
- 1977-01-31 RO RO197789185A patent/RO69712A/ro unknown
- 1977-11-14 AR AR269972A patent/AR216925A1/es active
1978
- 1978-11-07 AR AR274370A patent/AR216555A1/es active
1982
- 1982-08-30 US US06/412,591 patent/US4505894A/en not_active Expired - Fee Related
- 1982-12-16 CH CH734282A patent/CH638529A5/de not_active IP Right Cessation
1983
- 1983-07-14 KE KE3303A patent/KE3303A/xx unknown
- 1983-12-15 HK HK698/83A patent/HK69883A/xx unknown

Also Published As

Publication number	Publication date
PT66071B (en)	1978-06-23
FI770295A (de)	1977-08-01
ATA53477A (de)	1979-01-15
AT351675B (de)	1979-08-10
NO770279L (no)	1977-08-02
GR62544B (en)	1979-05-07
NZ183117A (en)	1979-10-25
IE44759L (en)	1977-07-31
MX4950E (es)	1983-01-12
NL7700892A (nl)	1977-08-02
FR2339616A1 (fr)	1977-08-26
DD128196A5 (de)	1977-11-02
DE2702954A1 (de)	1977-08-04
AR216555A1 (es)	1979-12-28
AR216925A1 (es)	1980-02-15
CH638529A5 (de)	1983-09-30
AR214306A1 (es)	1979-05-31
IE44759B1 (en)	1982-03-24
IL51267A0 (en)	1977-03-31
CS196341B2 (en)	1980-03-31
YU10777A (en)	1982-06-30
AU515736B2 (en)	1981-04-30
FI63581B (fi)	1983-03-31
AU2177077A (en)	1978-08-03
FR2339616B1 (de)	1980-04-11
JPS5295689A (en)	1977-08-11
CA1089471A (en)	1980-11-11
US4428958A (en)	1984-01-31
PT66071A (en)	1977-02-01
FI63581C (fi)	1983-07-11
PH13924A (en)	1980-11-04
JPS613349B2 (de)	1986-01-31
DK146940C (da)	1984-07-30
DK146940B (da)	1984-02-20
DK38577A (da)	1977-08-01
BG27751A3 (en)	1979-12-12
SE7700946L (sv)	1977-08-01
ES455404A1 (es)	1978-05-01
SE441359B (sv)	1985-09-30
RO69712A (fr)	1980-07-15
IL51267A (en)	1979-12-30
KE3303A (en)	1983-08-05
SU645583A3 (ru)	1979-01-30
CH637655A5 (de)	1983-08-15
US4505894A (en)	1985-03-19
LU76668A1 (de)	1977-06-28

Publication	Publication Date	Title
IL48824A0 (en)	1976-03-31	Thc-type compounds
JPS52151348A (en)	1977-12-15	Compound
JPS52125197A (en)	1977-10-20	Transshexahydroopyridooindole compound
JPS5297994A (en)	1977-08-17	Betaalactummcontaining compounds
JPS5317639A (en)	1978-02-17	Hexakisazo compounds
KE3303A (en)	1983-08-05	Therapeutic compounds containing beta-lactams
GB1539364A (en)	1979-01-31	11-deoxy-11-oxaprostaglandin compounds
CY1178A (en)	1983-06-10	21-halogenopregnane compounds
JPS52156899A (en)	1977-12-27	Compound
JPS52111590A (en)	1977-09-19	Novel cephalospoline compounds
ZA775065B (en)	1978-07-26	Anti-protozoal compounds
ZA77258B (en)	1977-11-30	Therapeutic compounds containing beta-lactams
ZA772175B (en)	1978-11-29	Oxothia compounds
JPS52102227A (en)	1977-08-27	Haloalkylphosphate compounds
ZA777335B (en)	1978-10-25	Pharmaceutical compounds
JPS5285216A (en)	1977-07-15	Azamethineemetal complex compounds
JPS5297990A (en)	1977-08-17	Cephalospoline compounds
ZA773470B (en)	1978-04-26	Substituted triazoles
JPS52125158A (en)	1977-10-20	Oxothia compound
JPS52100491A (en)	1977-08-23	Cephalospoline compounds
GB1542784A (en)	1979-03-28	Arylorganobromosilicone compounds
CY1211A (en)	1984-04-06	Azatetracyclic compounds
JPS5318555A (en)	1978-02-20	Compounds
JPS5297991A (en)	1977-08-17	Cephalospoline compounds
JPS5298735A (en)	1977-08-18	Pyrazoling compounds